Brief: Bioscrip Reports Qtrly Loss Per Share $0.14

Option Care Health

07/08/2018 13:10

Aug 7 (Reuters) - BioScrip Inc  BIOS.O :
    * BIOSCRIP REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS
    * Q2 REVENUE $175.8 MILLION VERSUS I/B/E/S VIEW $168.7
MILLION
    * SEES FY 2018 REVENUE $688 MILLION TO $698 MILLION
    * QTRLY LOSS PER SHARE $0.14
    * OPERATIONAL CASH FLOW IS EXPECTED TO RETURN TO MORE
NORMALIZED
LEVELS BEGINNING IN Q3 OF 2018
    * IMPLEMENTATION OF ASC 606 WILL NOT IMPACT OPERATING INCOME
OR
ADJUSTED EBITDA ON A GO-FORWARD BASIS
    * BIOSCRIP - REAFFIRMING 2018 GUIDANCE FOR REVENUE &
ADJUSTED
EBITDA
    * REMAIN INCREASINGLY CONFIDENT THAT CO CAN ACHIEVE AT LEAST
$75
MILLION IN ADJUSTED EBITDA IN 2019
    * Q2 EARNINGS PER SHARE VIEW $-0.12 -- THOMSON REUTERS
I/B/E/S

Source text for Eikon:  ID:nGNX7GPNSp 
Further company coverage:  BIOS.O 

 (Reuters.Briefs@thomsonreuters.com)